Dr. Ajit Singh , CEO of BioImagene , spoke yesterday on the importance of digital pathology in personalized medicine - a rapidly emerging field that promises to tailor diagnoses and therapies for individual patients based on their specific profiles. Dr. Singh was speaking on the occasion of the California Society of Pathologists (CSP) Annual Meeting in Los Angeles, CA.
CUPERTINO, Calif.----Dr. Ajit Singh, CEO of BioImagene, spoke yesterday on the importance of digital pathology in personalized medicine - a rapidly emerging field that promises to tailor diagnoses and therapies for individual patients based on their specific profiles.
New center marks the joining of two leading U.S. podiatric pathology providers -- CBLPath and the Laboratory of Podiatric Pathology (PRWeb Dec 3, 2008) Read the full story at http://www.prweb.com/releases/2008/12/prweb1691454.htm
NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), announced today that they have executed a Cooperative Research and Development Agreement (CRADA) with the Armed Forces Institute of Pathology (AFIP). This joint R&D effort will enable AFIP scientists to test the effectiveness of several NanoViricides, Inc. anti-viral nanomedicines against deadly bird flu viruses (H5N1) at their facilities.
